Syneron Medical Ltd. Reports Third Quarter 2016 Revenue Of $71.5 Million
IRVINE, Calif., Nov. 9, 2016 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended September 30, 2016.
Third Quarter 2016 Financial Highlights:
Revenue of $71.5 million, up 15.3% year-over-year
Product revenue up 18.6% year-over-year, including 19.5% North America and 18.1% international growth
Emerging products revenue of $24.1 million, which represents the Company's strategic growth drivers, grew 61% year-over-year
Total Body Shaping revenue of $14.2 million grew 46% year-over-year
GAAP earnings per share of $0.02, compared to GAAP loss per share of $(0.18) in Q3 2015; non-GAAP earnings per share of $0.08, compared to non-GAAP earnings per share of $0.03 in Q3 2015
Cash position as of September 30, 2016 of $82.9 million with no debt; generated $3.9 million in cash flow from operations
Third Quarter 2016 Financial Highlights:
Revenue of $71.5 million, up 15.3% year-over-year
Product revenue up 18.6% year-over-year, including 19.5% North America and 18.1% international growth
Emerging products revenue of $24.1 million, which represents the Company's strategic growth drivers, grew 61% year-over-year
Total Body Shaping revenue of $14.2 million grew 46% year-over-year
GAAP earnings per share of $0.02, compared to GAAP loss per share of $(0.18) in Q3 2015; non-GAAP earnings per share of $0.08, compared to non-GAAP earnings per share of $0.03 in Q3 2015
Cash position as of September 30, 2016 of $82.9 million with no debt; generated $3.9 million in cash flow from operations